U.S. Biotech Stock News

Earlier in February 2026, Warby Parker appointed Adrian Mitchell, a veteran retail executive and former Macy’s COO and CFO, as its new Chief Financial Officer, with Mitchell also becoming the company’s principal financial and accounting officer while co-founder Dave Gilboa continues as Co-CEO. Mitchell’s mix of retail operations, consulting, and board-level experience in consumer brands may be particularly relevant as Warby Parker scales new initiatives like AI glasses and expanded eye-care...

On 11 February 2026, Hiab announced a dealer agreement with Custom Truck One Source to expand sales and service coverage for HIAB loader cranes across 12 U.S. states and MOFFETT truck mounted forklifts across eight states. This agreement meaningfully broadens Custom Truck’s access to crane and forklift customers in key Western and Northeastern regions, deepening its role as an equipment solutions provider for infrastructure-related industries. We’ll now examine how this expanded Hiab...

Why Edwards Lifesciences (EW) is on investors’ radar Edwards Lifesciences (EW) has drawn attention after a mixed period for the stock, with gains over the past year and past 3 years set against weaker month and year to date returns. See our latest analysis for Edwards Lifesciences. Recent trading suggests momentum has cooled a little, with a 1-day share price return of 1.09% and a 7-day gain of 5.15%. These are set against weaker 30-day and year to date share price returns, while 1-year and...

Genuine Parts (NYSE:GPC) reported a significantly weaker quarter with full year profit dropping sharply. The company missed analyst expectations and highlighted a clear year over year earnings decline. Despite softer results, Genuine Parts raised its dividend for the 70th consecutive year. The company also reaffirmed that it is actively pursuing acquisitions as part of its growth plans. Genuine Parts, the parent company behind NAPA Auto Parts and other industrial distribution businesses,...

If you are looking at InterDigital and wondering whether the recent share price really reflects its underlying worth, you are not alone. The stock last closed at US$358.50, with a 1 year return of 72.7% and a 3 year return that is more than 4x, even after a 4.4% pullback over the past week and an 8.5% gain across the last 30 days. Recent news coverage has focused on InterDigital’s role in wireless and video technology licensing and its activity in intellectual property agreements. This helps...

Why Central Garden & Pet is on investors’ radar today Central Garden & Pet (CENT) has drawn attention after a strong recent run in the share price, with the stock showing gains over the past week, month, and past 3 months. See our latest analysis for Central Garden & Pet. Zooming out, the recent 23.3% 1 month share price return and 26.2% 3 month share price return for Central Garden & Pet contrasts with a more modest 6.6% 1 year total shareholder return. This suggests that momentum has...

CBRE Group (NYSE:CBRE) has acquired Pearce Services, expanding its reach in data center solutions. The deal adds field services and technical capabilities that support data center operations. CBRE continues to invest in AI and technology to improve service delivery and efficiency. These moves come as companies face macroeconomic challenges and look to outsource more real estate and technical functions. CBRE Group, a global commercial real estate services firm, now has an expanded foothold...

Texas Capital Bancshares recently removed its unused Series A-1 nonvoting common stock designation and eliminated its 6.50% Series A preferred stock class, reverting those shares to undesignated preferred stock, simplifying its capital structure without changing existing shareholder rights. Around the same time, director Robert Stallings bought 10,000 shares, aligning insider activity with analyst optimism around stronger earnings quality and business diversification. With this insider...

In February 2026, Medical Properties Trust reported fourth-quarter and full-year 2025 results showing higher sales and revenue, a swing from a very large prior-year loss to US$17.31 million in quarterly net income, and normalized funds from operations of US$0.18 per share that exceeded analyst expectations. The REIT also largely resolved its exposure to Prospect Medical Holdings’ bankruptcy through a new 15-year lease on six California hospitals, restructured its Vibra Healthcare...

Constellation Energy (CEG) is back in focus after filing an omnibus shelf registration that covers common and preferred stock, depositary shares and debt securities, just as investors watch for its upcoming earnings update. See our latest analysis for Constellation Energy. The latest 1 day share price return of 1.09% to US$294.84 and a 7 day share price return of 2.22% come after a tougher stretch, with a 90 day share price return decline of 16.74%. The 3 year total shareholder return of...

Eli Lilly (NYSE:LLY) reported major clinical trial successes across multiple drug programs. New long term efficacy data for Omvoh in Crohn’s disease highlighted durable treatment benefits. A combination trial of Taltz and Zepbound in patients with psoriasis and obesity produced landmark results. Retevmo delivered positive topline outcomes in early stage lung cancer in the latest study readout. Eli Lilly is a large global pharmaceutical company with a portfolio that spans autoimmune disease,...

Wondering if Keurig Dr Pepper at around US$29.54 is offering fair value or a potential opportunity? This article walks you through what the current price could be telling you. The stock has seen a 6.4% gain over the last 30 days and 6.5% year to date, but that sits against a 10.5% decline over the past year and a 9.6% gain across five years. Recent coverage of Keurig Dr Pepper has focused on its position in the US beverages and coffee market and how it fits into broader consumer staples...

If you are wondering whether Lithia Motors might be priced attractively right now, this article walks through what the market is paying for the stock compared with our estimate of its underlying value. The share price last closed at US$293.65, with returns of a 2.5% decline over 7 days, an 8.9% decline over 30 days, an 11.6% decline year to date and a 15.0% decline over 1 year, while the 3 year return sits at 16.3% and the 5 year return at a 20.1% decline. Recent headlines around Lithia...

The FDA has accepted Bristol-Myers Squibb’s New Drug Application for iberdomide in combination with other therapies for relapsed or refractory multiple myeloma. The filing has received both Breakthrough Therapy Designation and Priority Review from the FDA. The decision focuses on patients with hard to treat multiple myeloma who have limited options after prior therapies. Bristol-Myers Squibb (NYSE: BMY) now has iberdomide under Priority Review at a time when its shares trade around $60.66...

Praxis Precision Medicines (NasdaqGS:PRAX) has submitted two NDAs for ulixacaltamide and relutrigine, moving its lead programs toward potential commercialization. The FDA has granted breakthrough therapy designation to ulixacaltamide, signaling regulatory focus on the drug's potential for patients with neurological disorders. The NDAs are supported by positive Phase III data, and the company is preparing for its first commercial launches, with additional pivotal readouts planned for...

Autodesk has filed a lawsuit against Alphabet, alleging infringement of its "Flow" trademark in visual effects and production management products. The dispute centers on the use of the "Flow" name in tools aimed at film, TV, and digital content workflows. The case puts two large technology players in direct conflict over branding in the design and production software space. For investors watching NasdaqGS:ADSK, the lawsuit arrives after a period of weaker share performance. The stock is at...

In February 2026, Copart reported second-quarter revenue of US$1,121.67 million and net income of US$350.73 million, both lower than a year earlier, with earnings per share of US$0.36 missing analyst expectations. Despite weaker quarterly performance, Copart’s balance sheet remains strong, with substantial cash reserves, no debt, and ongoing share repurchases that underline management’s confidence in the business. We’ll now examine how Copart’s revenue and earnings shortfall, alongside...

Grab Holdings reported its 2025 results, delivering breakeven fourth-quarter earnings, full-year net income of US$268 million on sales of US$3.37 billion, alongside a new US$500 million share repurchase program and plans to adopt a Third Amended and Restated Memorandum and Articles of Association following a March 24, 2026 EGM. The company also marked its first full year of net profitability, while using its improved cash position to fund buybacks and expand into international wealth...

First Financial Bancorp (FFBC) has attracted fresh attention after a period of solid share performance, with recent returns over the past month and past 3 months prompting a closer look at how the bank’s fundamentals compare. See our latest analysis for First Financial Bancorp. At a share price of $30.36, First Financial Bancorp’s recent momentum is reflected in a 30 day share price return of 13.11% and a 90 day share price return of 24.94%. The 1 year total shareholder return of 16.58%...

Ivory Prize recognition and fresh earnings put Safehold in focus Safehold (SAFE) has landed on investors’ radars after becoming a finalist for the 2026 Ivory Prize for Housing Affordability, alongside reporting recent quarterly and full year results that showed year over year revenue and net income growth. See our latest analysis for Safehold. The Ivory Prize recognition and the latest earnings release have arrived alongside a 30 day share price return of 12.89% and a 90 day share price...

In February 2026, Travelers Companies launched its AI Claim Assistant, a fully agentic voice solution built on OpenAI models to handle auto damage claim calls, offering end-to-end support from initial consultation through claim submission and follow-up digital tasks like photo uploads, appraisals, and repair scheduling. By pairing this AI rollout with a deliberate upskilling and redeployment of call center staff into more complex roles, Travelers is signaling how it intends to blend...

Johnson Controls International recently reported stronger-than-expected fiscal Q1 2026 results, highlighting record orders, an approximately 20% increase in backlog to about US$18.00 billion, and higher full‑year earnings guidance driven by demand in data center cooling and life sciences. This combination of record backlog and upgraded guidance underscores how Johnson Controls is increasingly tying its growth to AI‑driven data centers and advanced life‑science infrastructure. We’ll now...

Recently, Alignment Healthcare reported continued expansion of its Medicare Advantage membership base and ongoing earnings growth, while senior executives sold shares under pre-arranged trading plans that left them with substantial ownership stakes. What stands out is how multiple analysts have responded to this membership momentum and earnings trajectory by revising their views upward, even as leadership’s planned stock sales signal portfolio management rather than a shift in...

Diversified Energy (DEC) has just completed a US$200 million tap of its 9.75% senior secured bonds in the Nordic market, adding to the existing US$300 million issue due in 2029. See our latest analysis for Diversified Energy. The bond tap arrives after a mixed period for the stock, with a 1 month share price return of 6.54% and a 7 day gain of 3.63%, contrasting with a 90 day share price decline of 7.50% and a 3 year total shareholder return decline of 36.81%. This suggests that short term...